Ontrak (OTRK) Competitors $1.45 -0.06 (-3.97%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock OTRK vs. CCM, ENZ, MRAI, MGRX, BRTX, KDLY, SSY, BGLC, ACON, and ATIPShould you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include Concord Medical Services (CCM), Enzo Biochem (ENZ), Marpai (MRAI), Mangoceuticals (MGRX), BioRestorative Therapies (BRTX), Kindly MD (KDLY), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. Ontrak vs. Concord Medical Services Enzo Biochem Marpai Mangoceuticals BioRestorative Therapies Kindly MD SunLink Health Systems BioNexus Gene Lab Aclarion ATI Physical Therapy Ontrak (NASDAQ:OTRK) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, community ranking, earnings and dividends. Do institutionals and insiders hold more shares of OTRK or CCM? 12.9% of Ontrak shares are held by institutional investors. 1.9% of Ontrak shares are held by insiders. Comparatively, 46.5% of Concord Medical Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in OTRK or CCM? Concord Medical Services received 159 more outperform votes than Ontrak when rated by MarketBeat users. However, 59.38% of users gave Ontrak an outperform vote while only 58.81% of users gave Concord Medical Services an outperform vote. CompanyUnderperformOutperformOntrakOutperform Votes3859.38% Underperform Votes2640.63% Concord Medical ServicesOutperform Votes19758.81% Underperform Votes13841.19% Which has more volatility & risk, OTRK or CCM? Ontrak has a beta of 2.93, suggesting that its stock price is 193% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.64, suggesting that its stock price is 164% less volatile than the S&P 500. Does the media refer more to OTRK or CCM? In the previous week, Concord Medical Services had 3 more articles in the media than Ontrak. MarketBeat recorded 5 mentions for Concord Medical Services and 2 mentions for Ontrak. Ontrak's average media sentiment score of 1.44 beat Concord Medical Services' score of -0.20 indicating that Ontrak is being referred to more favorably in the media. Company Overall Sentiment Ontrak Positive Concord Medical Services Neutral Do analysts recommend OTRK or CCM? Ontrak presently has a consensus target price of $45.00, suggesting a potential upside of 3,003.45%. Given Ontrak's stronger consensus rating and higher probable upside, research analysts plainly believe Ontrak is more favorable than Concord Medical Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Concord Medical Services 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is OTRK or CCM more profitable? Concord Medical Services has a net margin of 0.00% compared to Ontrak's net margin of -237.77%. Concord Medical Services' return on equity of 0.00% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets Ontrak-237.77% -171.34% -113.42% Concord Medical Services N/A N/A N/A Which has preferable earnings and valuation, OTRK or CCM? Ontrak has higher earnings, but lower revenue than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOntrak$10.85M0.56-$27.92M-$15.81-0.09Concord Medical Services$471.70M0.08-$41.93MN/AN/A SummaryOntrak beats Concord Medical Services on 9 of the 16 factors compared between the two stocks. Get Ontrak News Delivered to You Automatically Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OTRK vs. The Competition Export to ExcelMetricOntrakhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.12M$2.00B$5.57B$7.83BDividend YieldN/A7.12%5.11%4.22%P/E Ratio-0.1415.7322.4418.48Price / Sales0.563.75394.09103.59Price / CashN/A9.3238.1834.62Price / Book0.263.996.774.25Net Income-$27.92M$87.49M$3.22B$248.23M7 Day Performance-1.02%-0.63%1.49%0.89%1 Month Performance-0.41%-5.29%4.00%3.53%1 Year Performance-63.55%-26.48%16.21%5.08% Ontrak Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OTRKOntrak3.244 of 5 stars$1.45-4.0%$45.00+3,003.4%-64.7%$6.12M$10.85M-0.14250Short Interest ↓Positive NewsCCMConcord Medical Services0.5879 of 5 stars$4.26+3.1%N/A-4.0%$18.50M$471.70M0.00970Short Interest ↑ENZEnzo Biochem0.5442 of 5 stars$0.33-14.8%N/A-69.0%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeMRAIMarpaiN/A$1.01-3.8%N/A-50.7%$15.05M$34.87M-0.38150Upcoming EarningsMGRXMangoceuticals0.9072 of 5 stars$2.49-3.1%N/A-97.0%$12.87M$615,873.00-0.433Short Interest ↓Negative NewsBRTXBioRestorative Therapies3.868 of 5 stars$1.71-2.3%$18.00+952.6%+23.9%$12.83M$401,000.00-1.127Short Interest ↓KDLYKindly MD1.2804 of 5 stars$1.47-16.0%N/AN/A$8.86M$2.72M-2.23N/AShort Interest ↓Gap DownSSYSunLink Health SystemsN/A$0.94+3.5%N/A+64.6%$6.60M$31.23M6.701,376BGLCBioNexus Gene Lab0.259 of 5 stars$2.67-2.2%N/A-54.0%$4.80M$9.26M0.0030Short Interest ↑News CoverageGap DownACONAclarion1.5023 of 5 stars$7.93-11.7%$11,758.50+148,178.7%-99.8%$4.62M$45,724.000.007Short Interest ↑News CoverageATIPATI Physical TherapyN/A$1.00+17.6%N/A-80.9%$4.41M$741.86M-0.055,600Upcoming EarningsGap Up Related Companies and Tools Related Companies CCM Competitors ENZ Competitors MRAI Competitors MGRX Competitors BRTX Competitors KDLY Competitors SSY Competitors BGLC Competitors ACON Competitors ATIP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OTRK) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ontrak, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ontrak With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OTRK Stock Free OTRK Stock Alerts